Point72 Asset Management
AIMT

Point72 Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-771,126
Closed -$12.9M 1116
2020
Q2
$12.9M Sell
771,126
-773,686
-50% -$12.9M 0.08% 269
2020
Q1
$22.3M Buy
+1,544,812
New +$22.3M 0.18% 157
2019
Q4
Sell
-601,813
Closed -$12.6M 1301
2019
Q3
$12.6M Buy
601,813
+81,397
+16% +$1.7M 0.08% 287
2019
Q2
$10.8M Buy
+520,416
New +$10.8M 0.06% 318
2019
Q1
Sell
-613,461
Closed -$14.7M 1194
2018
Q4
$14.7M Buy
613,461
+231,081
+60% +$5.53M 0.07% 283
2018
Q3
$10.4M Sell
382,380
-1,306,403
-77% -$35.6M 0.04% 358
2018
Q2
$45.4M Buy
1,688,783
+608,883
+56% +$16.4M 0.18% 121
2018
Q1
$34.4M Sell
1,079,900
-159,346
-13% -$5.07M 0.14% 157
2017
Q4
$46.9M Buy
1,239,246
+141,159
+13% +$5.34M 0.2% 115
2017
Q3
$27.2M Buy
1,098,087
+101,855
+10% +$2.53M 0.12% 176
2017
Q2
$20.5M Buy
996,232
+314,259
+46% +$6.46M 0.11% 204
2017
Q1
$14.8M Buy
681,973
+274,273
+67% +$5.96M 0.08% 287
2016
Q4
$8.34M Buy
+407,700
New +$8.34M 0.06% 324